Branchburg,
March
06, 2013, ---Hydromer, Inc. (HYDI.PK)
announced that it entered into a royalty bearing
Exclusive License Agreement
with Ortopro AS (Ortopro)of
Turkey.

Under
the
terms of this agreement, OrtoPro is licensed to
use proprietary Hydromer®
biofilm resistant coatings on various implantable
orthopedic devices, such as bone
screws.Test
data has indicated that the
licensed Hydromer coating formulation aids in
reducing the infection risk of
such implants.Ortopro has agreed to
conduct additional biological and biocompatibility
studies hopefully leading to
regulatory approval in the Exclusive Territory of
Turkey.

“We
are
tremendously proud and honored with our new
relationship, which will help
propel Hydromer’s entry into the lucrative
orthopedic implant market”,
commented Martin von Dyck, Executive Vice
President of Hydromer, Inc., adding,
“Hydromer and Ortopro have been working closely
together in addressing the
vexing problem of infections associated with
orthopedic implants which are very
difficult to resolve using conventional
intravenous antibiotic therapy.In fact,
often an infected implant must be
removed or treated via another surgical procedure.It is
our belief that the new Hydromer
formula will mitigate this infection risk”